<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Prostacyclin (<z:chebi fb="0" ids="15552">PGI2</z:chebi>) and <z:chebi fb="0" ids="15627">thromboxane A2</z:chebi> (TxA2) formation by whole-tissue segments of nine carotid endarterectomy specimens (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CES</z:e>), five <z:mpath ids='MPATH_458'>normal</z:mpath> aortic specimens (NAS), six saphenous vein specimens (SVS), and four platelet samples were determined by incubation with 10 mumol/L 1-14C-radiolabeled <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> endoperoxide H2 (<z:chebi fb="0" ids="15554">PGH2</z:chebi>), and in other experiments with and without 10 mumol/L of CGS 13080, a TxA2 synthase inhibitor </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="15552">PGI2</z:chebi> formation (expressed as picomoles 6-keto-<z:chebi fb="0" ids="28852">PGF1 alpha</z:chebi>/2-min incubation per sample) by nonatheromatous proximal intima of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CES</z:e> (307 +/- 23, mean +/- standard error) and distal intima of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CES</z:e> (260 +/- 22) was not statistically different; however, it was greater than atheromatous transitional plaque (159 +/- 13 pmol) (p less than 0.01) and ulceration regions (140 +/- 15 pmol) (p less than 0.01) of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CES</z:e>, NAS (204 +/- 16 pmol) (p less than 0.01), and SVS (165 +/- 9 pmol) (p less than 0.01) </plain></SENT>
<SENT sid="2" pm="."><plain>TxA2 formation (expressed as picomoles TxB2/2-min incubation per sample) by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CES</z:e> ulceration (51 +/- 2 pmol) was low but greater than proximal (17 +/- 2 pmol) (p less than 0.01), distal (19 +/- 3 pmol) (p less than 0.01), and transitional (23 +/- 3 pmol) (p less than 0.01) regions </plain></SENT>
<SENT sid="3" pm="."><plain>TxA2 formation by NAS and SVS was not detected (less than 10 pmol) </plain></SENT>
<SENT sid="4" pm="."><plain>CGS 13080 inhibited TxA2 formation by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CES</z:e> below the limits of detection </plain></SENT>
<SENT sid="5" pm="."><plain>Incubation of 1.9 x 10(5) intact platelets with 10 mumol/L of <z:chebi fb="0" ids="15554">PGH2</z:chebi> formed a quantity of TxA2 equal to that of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CES</z:e> ulceration.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>